Additionally, the DNA hyerpmutation triggered by B-Myb is less efficient than by A3B, suggesting that B-myb acts upstream of A3B and induces A3B expression than directly catalyzes C residues deamination in breast cancer cells. Here, APOBEC3B is linked to breast carcinoma.